Many drug related notices . . .

The United States Patent and Trademark Office Gave METP Pharma US Patent Treating Demyelinating as well as Neuroinflammatory Diseases
The United States Patent and Trademark Office gave MetP Pharma US Patent treating Demyelinating, as well as, Neuroinflammatory Diseases-Industry Global News24

Tiglutik
FDA Approves New Indication for Tiglutik for ALS
FDA Approves New Indication for Tiglutik for ALS - Specialty Pharmacy Continuum

FDA Approves Broader Label for ALS Drug, Riluzole
FDA Approves Broader Label for ALS Drug, Riluzole | Managed Care magazine

Amylyx (AMX0035)
ALS Drug Works in Study, Researchers Say
ALS Drug Works in Study, Researchers Say - WSJ

Amylyx drug helps slow ALS progression in mid-stage study
Amylyx drug helps slow ALS progression in mid-stage study | News | WKZO

ALS Researchers Concoct New Drug to Help Slow Progression of Lou Gehrig’s Disease
https://sputniknews.com/society/2019...hrigs-disease/

ALS drug ‘significantly’ slows disease progression in late-stage trial
https://www.mcknights.com/news/clini...e-stage-trial/

Reldesemtiv
Cytokinetics' reldesemtiv an Orphan Drug in U.S.
https://seekingalpha.com/news/352703...an-drug-in-u-s

miR-218
ALS Genomic Analysis Highlights Potential MicroRNA Contributor
https://www.genomeweb.com/sequencing...na-contributor

MSC-NTF cells (NurOwn)
BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology
https://dodsondigest.com/brainstorm-...-in-neurology/

Ionis licenses investigational Alzheimer's therapy
https://finance.yahoo.com/news/ionis...120500216.html

Arimoclomol and Aldoxorubicin
CytRx Corporation Highlights Significant Positive Events From its Two Licensed Drugs Arimoclomol and Aldoxorubicin
https://www.prnewswire.com/news-rele...300977445.html

Google’s A.I. "Project Euphonia"
The never-ending war against ALS gains a weapon in technology
https://www.clnsmedia.com/never-endi...on-technology/

Thought to speech
Meet the Neuroscientist Translating Brain Activity Into Speech
https://www.discovermagazine.com/min...ty-into-speech

Is Rolls Royce Giving Voice To ALS (Amyotrophic Lateral Sclerosis) Patients With New AI Tech?
https://www.edtimes.in/is-rolls-royc...h-new-ai-tech/

medical marijuana
Getting a medical marijuana card is easier than ever — and it could help you avoid lines, save money when recreational sales start
https://chicago.suntimes.com/cannabi...s-recreational

AstroRx® cells
Kadimastem Announces the Completion of Treatment for Cohort B of Its Phase 1/2a Clinical Trial in ALS Patients
https://www.prnewswire.com/news-rele...300979013.html

Roche hands $1B to Sarepta in major return to gene therapy deals
https://www.biopharmadive.com/news/r...y-deal/569599/

This is the largest set of year-end research disclosures I have ever seen. Not big fan of this year, kind-a-glad its almost over but nice to seen bunch of this sort of news.